Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0M00
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,092
Award facts
- Contract value 100% obligated
- $27,091.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,091.63 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract was competitively awarded with no set-aside designation and carries firm fixed-price pricing terms. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, making this delivery order part of the broader federal medical supply chain supporting military healthcare systems and other government agencies.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), maintains an even larger IDC with DLA valued at up to $1 billion through December 31, 2031. These contract vehicles enable comprehensive pharmaceutical and medical supply support to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally, positioning AmerisourceBergen as a critical vendor in the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26F0M00?
SPE2DR26F0M00 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F0M00 worth?
The government has obligated $27,092 on SPE2DR26F0M00.
Is contract SPE2DR26F0M00 an order under another contract?
Yes. SPE2DR26F0M00 is a delivery order under SPE2DR25D2207, an indefinite delivery contract.
Was contract SPE2DR26F0M00 competed?
The extent of competition for SPE2DR26F0M00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award